Here's Why Arquitos Capital Management Largely Exited Lifecore (LFCR) [Yahoo! Finance]
Lifecore Biomedical, Inc. (LFCR)
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . The strategy returned -15.5% in the third quarter of 2024, bringing the year-to-date return to 4.5%. This year has witnessed quite a bit of volatility as usual. Prior to the decline this summer, the strategy was up over 40% at one time. Since the conclusion of the third quarter, the firm is operating well once more and expecting a successful year-end. In addition, please check the fund's top five holdings to know its best picks in 2024. Arquitos Capital Management highlighted stocks like Lifecore Biomedical, Inc. (NASDAQ: LFCR ) in the third quarter 2024 investor letter. Lifecore Biomedical, Inc. (NASDAQ:LFCR) is an integrated contract development and manufacturing organization. The one-month return of Lifecore Biomedical, Inc. (NASDAQ:LFCR) was 16.17%, and its shares gained 30.20% of their value over the last 52 weeks. On December 11, 2024, Lifecore Biomedical, Inc. (NASDAQ:LFCR) stock closed at $7.76 per share with a market capitalizat
Show less
Read more
Impact Snapshot
Event Time:
LFCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFCR alerts
High impacting Lifecore Biomedical, Inc. news events
Weekly update
A roundup of the hottest topics
LFCR
News
- Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 [Yahoo! Finance]Yahoo! Finance
- Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025GlobeNewswire
- Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment [Yahoo! Finance]Yahoo! Finance
- Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder TreatmentGlobeNewswire
- Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire
LFCR
Sec Filings
- 12/10/24 - Form 4
- 12/10/24 - Form 4
- 11/12/24 - Form SC
- LFCR's page on the SEC website